BIO Europe 2026

    Cologne, Germany 9-11 November 2026

    South Australia’s health ecosystem

    South Australia is characterised by deep clinical research, manufacturing and an end-to-end value chain supported by world-class infrastructure and digital capabilities. It is an exceptionally collaborative and connected ecosystem for drug development, advanced manufacturing and data-driven health innovation.

    This makes Adelaide and South Australia the perfect location to collaborate, innovate and trial new products, ready for global commercialisation.

    South Australia provides the fastest pathway for clinical trial conduct with data accepted by regulatory agencies globally, offering speed, quality and value in medical research.

    Invest SA within the Department of State Development, partners directly with domestic and international organisations, investors and industry leaders to identify commercial opportunities and enable successful market entry, expansion and collaboration.

    For more information download the South Australian Clinical Trials Connected Health Innovation PDF below:

    South Australian advantage

    Australia’s most experienced providers operate in South Australia, creating the nation’s most comprehensive, connected and supportive clinical trial ecosystem, providing leadership across the entire supply chain.

    • Local ethics approval and an advanced ecosystem enable you to start trials in five to six weeks
    • Save resources by working with experienced partners who offer specialised advice, increasing efficiency, reducing risk and adding value during trial exploration, setup and conduct

    South Australia’s unique ecosystem provides a trusted, connected environment for companies to partner and innovate.

    Leverage the South Australian advantage:

    Speed

    Efficient regulatory framework saves up to one year in regulatory timelines

    • Investigational new drug application (IND) not required for Phase 1 studies

    Quality

    • Globally accepted data with the highest quality standards for submission to regulatory agencies including the US FDA, UK MHRA, EU EMA and Japan PDMA.

    Value

    • R&D tax incentive program

    South Australia’s capabilities

    Fastest pathway for clinical trial conduct

    Enabling trials to start in five to six weeks

    43.5% R&D tax incentive program

    Supporting companies across R&D activities in Australia

    Australia’s best longitudinal clinical data set

    Statewide electronic medical record linked to Australia’s largest pathology and medical imaging providers

    Complete clinical trial ecosystem

    Clinical trials data accepted by global regulatory agencies

    State of the art GMP manufacturing

    R&D to commercial scale, small and large molecules and radiopharmaceuticals

    At the forefront of biotech R&D

    World-class biotech, including vaccine, microbiome and CAR T-cell research

    Connect with South Australia to advance your drug development

    Organisations at BIO Europe

    AGILEX 8

    Agilex Biolabs

    Agilex Biolabs is Australia’s largest bioanalytical laboratory, with nearly 30 years’ experience in regulated bioanalysis. The laboratories feature state-of-the-art equipment, including Sciex Triple Quad 6500+, MSD Quickplex 120, Cytek Aurora, BD FACSymphony A3, and droplet digital PCR, enabling comprehensive bioanalytical services. Agilex holds ISO/IEC17025 accreditation, OECD GLP recognition with NATA, and ISO27001:2022 certification for information security, ensuring the highest quality standards.
    Avance Clinical 8

    Avance Clinical

    Avance Clinical is a full-service Contract Research Organisation (CRO) headquartered in Australia, with extensive operations across North America, including its office in North Carolina, Asia and New Zealand. With more than 30 years of experience leading early phase clinical trials, it leverages the unique advantages of the Australian market, including rapid ethics approval, no IND requirement, and up to 43.5% off with the Australian R&D tax rebate, to provide biotechs with an accelerated pathway to clinical success.
    Bellberry 8

    Bellberry Limited

    Bellberry Limited is an Australian award-winning independent, not-for-profit organisation offering Human Research Ethics Committee (HREC) services. Driven by two key objectives, to protect the welfare of research participants and improve the quality, efficiency and effectiveness of research, Bellberry provides high-quality, time-efficient, and internationally accredited scientific and ethical review of research projects.
    Bentleys 8

    Bentleys

    Bentleys is an accounting and advisory firm located across Australia and New Zealand, and is part of Allinial Global, with firms located in more than 70 countries. Bentleys’ reputation in R&D tax incentives, innovation advisory and tax consulting is built on results. Bentleys has helped organisations secure hundreds of millions of dollars in government funding and incentives to support research, development and commercialisation initiatives worldwide.
    Bio Cina 8

    BioCina

    BioCina is an end-to-end CDMO, bringing more than 50 years of pharmaceutical manufacturing heritage to biologic drug substance and sterile drug product manufacturing, from clinical through commercial scale. Our drug substance expertise spans microbial fermentation, plasmid DNA, and mRNA with LNP encapsulation, based at their Adelaide facility.
    CMAX 8

    CMAX Clinical Research

    CMAX Clinical Research has been a leader in delivering early phase clinical trials for over 30 years, making it one of the most respected clinical trial businesses in Australia. Their modern custom-built facility is equipped with 78 inpatient beds and located opposite the Royal Adelaide Hospital and Adelaide’s BioMed City, providing ready access to state-of-the-art facilities, equipment and world-class medical and pharmacology specialists.
    Flinders University Logo

    Flinders University

    Flinders University is recognised for research excellence across health, care, biomedical and clinical sciences, and wellbeing. Its strengths include pioneering work in sleep science, ageing, aged care and palliative care, cancer, health equity, mental health, eye and vision health, First Nations health, and the wellbeing of military, veterans and first responders.
    Rdi partners 8

    RDI Partners

    RDI Partners is a national market leader in structuring and delivering compliant, low-cost Australian R&D incentive solutions for foreign-controlled groups that seek to establish a presence in Australia.

    Connect with South Australia to advance your drug development for global markets

    Dr Sandra Hack

    https://cms.business.sa.gov.au/assets/uploads/content/DSD/Bio-Europe/SandraHack.jpg

    Business Development Manager, Health & Medical Industries

    South Australian Government

    T: +61 435 100 052

    E: sandra.hack@sa.gov.au

    w: invest.sa.gov.au/sectors/health-and-medical

    Pallavi Mishra

    https://cms.business.sa.gov.au/assets/uploads/content/DSD/Bio-Europe/Pallavi-Mishra-United-Kingdom-and-Europe.jpg

    Trade and Investment Manager

    Germany

    South Australian Government

    T: +49 175 5045002

    E: Pallavi.mishra@austrade.gov.au

    W: invest.sa.gov.au/global_offices/united-kingdom-and-europe